Macular Pigment Distribution as Prognostic Marker for Disease Progression in Macular Telangiectasia Type 2

Am J Ophthalmol. 2018 Oct:194:163-169. doi: 10.1016/j.ajo.2018.07.017. Epub 2018 Jul 24.

Abstract

Purpose: To evaluate macular pigment distribution pattern as a prognostic marker for disease progression in patients with macular telangiectasia type 2 (MacTel).

Design: Retrospective cohort study.

Methods: In this single-center study, 90 eyes of 47 patients were analyzed. Macular pigment optical density (MPOD) was measured with dual-wavelength fundus autofluorescence. Eyes were graded into MPOD distribution classes 1 to 3 with increasing loss of macular pigment and grading was performed masked by 2 independent graders. Best-corrected visual acuity, reading acuity, total scotoma size in fundus-controlled perimetry (microperimetry), and break of the ellipsoid zone (EZ) in optical coherence tomography (en face measurement) were defined as functional and morphologic outcome parameters and evaluated at baseline and after 60 months.

Results: After a mean review period of 59.6 months (±standard deviation 5.2 months), no change between MPOD classes was observed compared to baseline. Morphologic and functional deficits were limited to the area of MPOD loss. At last follow-up, a significant mean decrease of visual acuity and reading acuity as well as a significant mean increase of scotoma size and EZ break were observed in eyes assigned to MPOD classes 2 and 3, while outcome parameters remained stable in eyes of class 1.

Conclusions: The results indicate that MPOD and its distribution may serve as a prognostic marker for disease progression and functional impairment in patients with MacTel.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Biomarkers / metabolism*
  • Disease Progression
  • Female
  • Fluorescein Angiography / methods
  • Follow-Up Studies
  • Humans
  • Macular Pigment / metabolism*
  • Male
  • Middle Aged
  • Optical Imaging
  • Prognosis
  • Retinal Telangiectasis / diagnosis*
  • Retinal Telangiectasis / metabolism
  • Retrospective Studies
  • Tomography, Optical Coherence / methods
  • Visual Acuity / physiology
  • Visual Field Tests

Substances

  • Biomarkers
  • Macular Pigment